October 15, 2025 – McDermott Will & Schulte’s health & life sciences group are once again recognized in LMG Life Sciences, receiving USA nationwide rankings across seven categories. This achievement reflects the firm’s continued reputation as a premier destination for clients navigating high-stakes issues at the intersection of law, science, and business.

The team continues to be acknowledged for its depth of experience and strategic legal counsel. Known for guiding clients through complex patent litigation and intellectual property strategy, the group also excels in FDA regulatory matters, product liability disputes, and sensitive government and white-collar investigations. The firm’s work in antitrust, healthcare pricing and reimbursement, and patent prosecution further highlights the breadth and strength of the practice.

USA Nationwide rankings include:

• White-Collar/Government Investigations – Tier 2
• Antitrust – Tier 3
• FDA: Medical Device – Tier 3
• General Patent Litigation – Tier 3
• Healthcare Pricing & Reimbursement – Tier 3
• Patent Strategy & Management – Tier 3
• Patent Prosecution – Tier 3

In addition to the practice-wide accolades, LMG Life Sciences recognized 14 lawyers for their outstanding contributions.

LMG Life Sciences is the only legal directory dedicated entirely to the life sciences industry. Its annual rankings highlight leading firms and individual lawyers across key practice areas, drawing on in-depth submissions, client and peer feedback, and independent market research.

View the full list of rankings here.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.